SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
125.188 0.04 (0.04%)

NAV as on 30 Jan, 2015

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Dec 31, 14)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 70.05 23.24
Lupin Pharmaceuticals 37.80 12.54
Aurobindo Pharm Pharmaceuticals 29.63 9.83
Dr Reddys Labs Pharmaceuticals 26.44 8.77
Ranbaxy Labs Pharmaceuticals 23.03 7.64
Divis Labs Pharmaceuticals 18.21 6.04
Strides Arcolab Pharmaceuticals 17.21 5.71
Torrent Pharma Pharmaceuticals 16.13 5.35
Cadila Health Pharmaceuticals 14.32 4.75
Alembic Pharma Pharmaceuticals 8.68 2.88
Sector Allocation (Dec 31, 14)
  Sector   % 1-Year
High Low

Pharmaceuticals

99.60 99.60 96.68
Asset Allocation (%) (Dec 31, 14)
Class
%

Equity

99.60

Others / Unlisted

0.13

Debt

0.00

Mutual Funds

N.A

Money Market

0.78

Cash / Call

-0.51

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

62.02

Top 10

86.75
Sectors
%

Top 3

99.60
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.